Here is your One-Page Strategic Blueprint designed to win the hackathon. It synthesizes top-tier consulting research with your technical solution to prove that "EXL Integrity 360" is not just a tool, but a market-aligned product.
​Project: EXL Integrity 360
​Theme: From "Pay & Chase" to "Predict & Prevent"
​1. The Strategic Vision: What the Experts Say
​We aligned our solution with the 2025-2030 roadmaps from Deloitte and McKinsey, which state that the future of Payment Integrity lies in Generative AI and Pre-Payment Prevention.
​Deloitte (2025 Prediction): Generative AI will be the primary driver for fraud detection, potentially saving P&C and Healthcare insurers $80 billion to $160 billion by 2032. They explicitly recommend moving toward "multimodal" analysis (text, images, and financials) rather than just claim codes.
​McKinsey (2024 AI Opportunity): Reports that AI can reduce administrative costs by 13% to 25% by automating manual reviews. They emphasize that the next era of payments must be "programmable" and "embedded," shifting intelligence to the edge (pre-payment) rather than post-payment batched audits.
​Our Execution: We answer this call by building a Pre-Payment "Risk Engine" that uses GenAI to interpret complex data (Clinical Notes, Policies) instantly, moving EXL from a service provider to a technology leader.
​2. The "Why" Layer: Behavioral Forensics (Provider Profit & Loss)
​Current systems detect errors (What). We detect motives (Why). Research shows a direct correlation between financial distress and billing fraud.
​The Problem: Hospitals operating at a loss are statistically more likely to engage in "upcoding" or aggressive billing to survive. Rural and small hospitals, specifically, face "large, persistent losses" that deplete reserves, creating pressure to generate revenue by any means necessary.
​Our Innovation: We integrate the ProPublica Nonprofit Explorer API to pull real-time tax data (Form 990s).
​The Logic: If a provider’s Net Income is negative for 2 consecutive years, but their billing volume for "High Severity" codes spikes by 300%, this is not a clinical anomaly—it is a financial survival strategy.
​The Result: A "Financial Distress Flag" that predicts fraud before the claim is even reviewed.
​3. The Validation Layer: Clinical & Market Reality
​We validate our "Behavioral Risk" with two external truth sources: Clinical Science (BioPython) and Market Demand (Google Trends).
​A. Clinical Truth: BioPython & PubMed
​The Concept: Fraudsters often bill for treatments that are "medically unnecessary" or "experimental" but code them as standard.
​The Tech: We use BioPython to automate literature searches on PubMed.
​The Workflow:
​Extract the "Diagnosis" and "Treatment" from the claim.
​Use BioPython to query PubMed: *"Efficacy of [Treatment] for [Diagnosis]."
​If the top 10 clinical papers say "No Evidence" or "Experimental," the claim is auto-flagged for Medical Necessity Review.
​Validation: This aligns with Deloitte's finding that "Text Analytics" and NLP are critical for identifying inconsistencies in claims data.
​B. Market Truth: Google Trends
​The Concept: "Manufactured Demand." Legitimate spikes in claims (e.g., Flu season) should match spikes in public interest (Search Volume). Fraudulent spikes (e.g., a sudden boom in "Allergy Shots" at one clinic) will not.
​The Tech: We use Google Trends (via pytrends) as a surveillance tool.
​The Workflow:
​Leading Indicator: Search volume for symptoms (e.g., "Knee Pain").
​Lagging Indicator: Insurance Claims for "Knee Surgery."
​The Trap: If Claims for Knee Surgery rise +500% but Search for Knee Pain is Flat (0%), the demand is artificial.
​Validation: Research confirms Google Trends is a valid "early warning tool" for health phenomena, allowing us to spot "Supply-Induced Demand" instantly.
​Summary: The "Proactive" Value Chain
​By combining these three layers, we create a product that:
​Predicts Risk (Consulting Vision)
​Identifies Motive (Financial Distress)
​Validates Reality (PubMed & Trends)
​This is the definition of Next-Gen Payment Integrity.
